Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Cureus|April 30, 2026
Presumed Infected Bronchogenic Cyst Presenting as Acute Pericarditis: A Case ReportXante Mentens, Yanina Jansen, Karel Wallecan, et al.
Annals of Thoracic Surgery Short Reports|January 10, 2025
Sternal Elevation by Crane Technique During Double Lung Transplant for Patient With Pectus ExcavatumArizona Binst, Yanina Jansen, Laurens J Ceulemans, et al.
Case Reports in Oncological Medicine|June 12, 2015
A Case Report of Long-Term Survival following Hepatic Arterial Infusion of L-Folinic Acid Modulated 5-Fluorouracil Combined with Intravenous Irinotecan and Cetuximab Followed by Hepatectomy in a Patient with Initially Unresectable Colorectal Liver MetastasesKobe Van Bael, Yanina Jansen, Teofila Seremet, et al.
The Lancet. Oncology|March 8, 2017
Combination of dabrafenib plus trametinib for BRAF and MEK inhibitor pretreated patients with advanced BRAFV600-mutant melanoma: an open-label, single arm, dual-centre, phase 2 clinical trialMax Schreuer, Yanina Jansen, Simon Planken, et al.
The Journal of Clinical Endocrinology and Metabolism|August 30, 2016
Incidence of Thyroid-Related Adverse Events in Melanoma Patients Treated With PembrolizumabJeroen de Filette, Yanina Jansen, Max Schreuer, et al.
European Journal of Pediatric Surgery Reports|November 5, 2024
Pulmonary Inflammatory Myofibroblastic Tumor: A Case ReportLotte Bruyninckx, Paul De Leyn, Dirk Van Raemdonck, et al.
Melanoma Research|December 12, 2017
Illustrative cases for monitoring by quantitative analysis of BRAF/NRAS ctDNA mutations in liquid biopsies of metastatic melanoma patients who gained clinical benefits from anti-PD1 antibody therapyTeofila Seremet, Simon Planken, Max Schreuer, et al.
Melanoma Research|December 5, 2015
Applications for quantitative measurement of BRAF V600 mutant cell-free tumor DNA in the plasma of patients with metastatic melanomaMax Schreuer, Geert Meersseman, Sari van Den Herrewegen, et al.
Melanoma Research|September 14, 2018
Successful treatment with intralesional talimogene laherparepvec in two patients with immune checkpoint inhibitor-refractory, advanced-stage melanomaTeofila Seremet, Simon Planken, Julia K Schwarze, et al.
Melanoma Research|February 3, 2015
Successful (neo)adjuvant BRAF-targeted therapy in a patient with locally advanced BRAF V600E mutant melanomaTeofila Seremet, Danielle Lienard, Mariano Suppa, et al.
Pageof 3